Vaccine-Associated Shifts in SARS-CoV-2 Infectivity Among the Native Hawaiian and Other Pacific Islander Population in Hawaii.
other
Where this comes from
- Record sourced from PubMed, PMID 36108254.
- Also identified by DOI 10.2105/AJPH.2022.306973 and PMC identifier 9707710.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Native Hawaiians and other Pacific Islanders (NHPIs) across the country have experienced significant disparities because of the COVID-19 pandemic. The Pacific Alliance Against COVID-19 used a community-based participatory approach involving academic and community partners to expand sustainable COVID-19 testing capacity and mitigate the severe consequences among NHPI communities in Hawaii. We describe the approach of this one-year study, some of the results, and how the data are being used to inform next steps for the communities. Clinical Trials.gov identifier: NCT04766333. (<i>Am J Public Health</i>. 2022;112(S9):S896-S899. https://doi.org/10.2105/AJPH.2022.306973).
Medical subject headings
- COVID-19
- Vaccines